XYL
Xylem Inc
107.60$
+0.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Investor relations
Report Dates
Investor relations overview for Xylem Inc (XYL): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 10/27/2026.
Next report
10/27/2026
Last report
07/28/2026
EPS estimate beaten
Full history
43 of 60 quarters (72%)
Last 16 quarters
15 of 16 quarters (94%)
Earnings Call Transcripts
- 07/28/2026 Earnings Call Q2 2026 Open →
- 04/28/2026 Earnings Call Q1 2026 Open →
- 02/10/2026 Earnings Call Q4 2025 Open →
- 10/28/2025 Earnings Call Q3 2025 Open →
- 07/31/2025 Earnings Call Q2 2025 Open →
- 04/29/2025 Earnings Call Q1 2025 Open →
- 02/04/2025 Earnings Call Q4 2024 Open →
- 10/31/2024 Earnings Call Q3 2024 Open →
- 07/30/2024 Earnings Call Q2 2024 Open →
- 05/02/2024 Earnings Call Q1 2024 Open →
News on This Stock
- 09/08/2026 Xylem Inc. (XYL): Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Financial Statements and Exhibits · sec.gov Open ↗
- 08/18/2026 Xylem Inc. (XYL): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
- 08/13/2026 Xylem Inc. (XYL): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits · sec.gov Open ↗
- 07/28/2026 Xylem Inc. (XYL): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
Automatically matched wire and portal stories; external links open the original source.
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.